Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model

Multiple vaccines have been developed and licensed for SARS-CoV-2. While these vaccines reduce disease severity, they do not prevent infection, and SARS-CoV-2 continues to spread and evolve. To prevent infection and limit transmission, vaccines must be developed that induce immunity in the respirato...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, DR, Minns, AM, Sim, DG, Field, CJ, Kerr, AE, Heinly, T, Luley, EH, Rossi, R.M., Bator, C., Moustafa, I.M., Hafenstein, SL, Lindner, SE, Sutton, TC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628200/
https://www.ncbi.nlm.nih.gov/pubmed/36324809
http://dx.doi.org/10.1101/2022.10.27.514054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628200/
https://www.ncbi.nlm.nih.gov/pubmed/36324809
http://dx.doi.org/10.1101/2022.10.27.514054

Ejemplares similares